Published in J Cell Physiol on June 01, 1997
The effect of erythropoietin on normal and neoplastic cells. Biologics (2012) 0.98
The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance. Blood (2013) 0.86
Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis. Mol Cell Biol (1999) 0.79
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia (2010) 2.65
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia (2013) 1.97
Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage. Nature (1985) 1.87
Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A (1983) 1.68
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. Leukemia (2005) 1.65
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. Leukemia (2010) 1.63
The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol (1995) 1.61
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol (1998) 1.55
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51
Palmitylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum. J Biol Chem (1989) 1.45
Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition. J Clin Invest (1986) 1.39
Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol (1989) 1.37
Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells (1994) 1.35
Role of signal recognition particle in the membrane assembly of Sindbis viral glycoproteins. Eur J Biochem (1984) 1.34
Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res (1990) 1.30
Free diffusion to and from the inner nuclear membrane of newly synthesized plasma membrane glycoproteins. J Cell Biol (1987) 1.27
Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver. Proc Natl Acad Sci U S A (1984) 1.24
Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci U S A (1991) 1.19
In vitro study of the NS2-3 protease of hepatitis C virus. J Virol (1997) 1.18
Biochemical fractionation and assembly of the membrane components that mediate nascent chain targeting and translocation. Cell (1991) 1.18
Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. Blood (2000) 1.14
Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A (1991) 1.12
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients. Leukemia (2011) 1.08
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia. Leukemia (2013) 1.06
Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood (1992) 1.03
In vivo expansion of purified hematopoietic stem cells transplanted in nonablated W/Wv mice. Exp Hematol (1999) 1.03
Leukemia risk models in primary myelofibrosis: an International Working Group study. Leukemia (2012) 1.01
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. Leukemia (2011) 1.00
Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues. J Cell Biol (1992) 1.00
Development of humanized mice for the study of hepatitis C virus infection. Transplant Proc (2006) 1.00
Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. Bone Marrow Transplant (1994) 0.99
Biosynthesis and oligosaccharide structure of human CD8 glycoprotein expressed in a rat epithelial cell line. J Biol Chem (1992) 0.99
Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switches. Proc Natl Acad Sci U S A (1980) 0.97
Cloning of human erythroid progenitors (BFU-E) in the absence of fetal bovine serum. Br J Haematol (1987) 0.96
Stable and unstable transgene integration sites in the human genome: extinction of the Green Fluorescent Protein transgene in K562 cells. Gene (2000) 0.96
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia (2009) 0.95
Identification and characterization of three classes of erythroid progenitors in human fetal liver. Blood (1981) 0.94
Chimeric Sindbis viruses dependent on the NS3 protease of hepatitis C virus. J Virol (1997) 0.93
A new determinant of endoplasmic reticulum localization is contained in the juxtamembrane region of the ectodomain of hepatitis C virus glycoprotein E1. J Biol Chem (2000) 0.92
Biosynthesis of Hb in individual fetal liver bursts. gamma-Chain production peaks earlier than beta-chain in the erythropoietic pathway. Exp Cell Res (1980) 0.91
Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol (1991) 0.91
Reconstitution of secretory protein translocation from detergent-solubilized rough microsomes. Methods Cell Biol (1991) 0.91
In vitro interactions of PGE and cAMP with murine and human erythroid precursors. Blood (1980) 0.91
Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. Br J Cancer (2006) 0.90
The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors. Bone Marrow Transplant (1998) 0.89
Stem cell factor induces proliferation and differentiation of fetal progenitor cells in the mouse. Br J Haematol (1998) 0.89
Regional distribution of Sindbis virus glycoproteins on the plasma membrane of infected baby hamster kidney cells. Exp Cell Res (1987) 0.88
Increased expression of the distal, but not of the proximal, Gata1 transcripts during differentiation of primary erythroid cells. J Cell Physiol (1999) 0.88
Kinetics of erythroid precursors in mice infected with the anemic or the polycythemic strain of Friend leukemia virus. Proc Natl Acad Sci U S A (1980) 0.87
Influence of recombinant hematopoietins and of fetal bovine serum on the globin synthetic pattern of human BFUe. Blood (1990) 0.87
Synergism between erythropoietin and interleukin-3 in the induction of hematopoietic stem cell proliferation and erythroid burst colony formation. Blood (1988) 0.87
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. Leukemia (2009) 0.87
WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential. Leukemia (2005) 0.87
Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chains. Blood (1980) 0.86
Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica (1996) 0.86
Human embryonic hemopoiesis: control mechanisms underlying progenitor differentiation in vitro. Dev Biol (1988) 0.85
Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase. Xenobiotica (2006) 0.84
Proliferation of purified murine hemopoietic stem cells in serum-free cultures stimulated with purified stem-cell-activating factor. Exp Hematol (1986) 0.84
Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation. Bone Marrow Transplant (2007) 0.84
The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients. Leukemia (2006) 0.84
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis. Leukemia (2013) 0.84
Lineage-restricted expression of protein kinase C isoforms in hematopoiesis. Blood (1999) 0.84
In vivo selection of protease cleavage sites by using chimeric Sindbis virus libraries. J Virol (2000) 0.83
Long-term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3. Blood (1994) 0.83
Regulation of differentiation of murine progenitor cells derived from blast cell colonies under serum-deprived conditions. Exp Hematol (1989) 0.83
Erythropoietin-specific cell cycle progression in erythroid subclones of the interleukin-3-dependent cell line 32D. Blood (1993) 0.83
Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses. J Virol (1999) 0.82
The biology of hematopoietic growth factors: studies in vitro under serum-deprived conditions. Exp Hematol (1990) 0.82
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32 D. Prog Clin Biol Res (1989) 0.82
Different patterns of platelet turnover in chronic idiopathic thrombocytopenic purpura. Scand J Haematol (1983) 0.82
Induced crossing-over in Drosophila melanogaster germ cells of DNA repair-proficient and repair-deficient (mei-9L1) males following larval feeding with 5-azacytidine and mitomycin C. Mutat Res (1992) 0.82
Establishing an employee baseline purified protein derivative status in the division of immigration health Service Processing Centers. J Community Health (2001) 0.82
Megakaryocyte-like increase in ploidy of Friend's erythroleukemia cells induced to endoreplication by colcemid. Exp Hematol (1996) 0.81
Molecular control of erythroid differentiation. Int J Hematol (1996) 0.81